What is unknown is whether early treatment with GH in these patients is effective in improving height outcomes or, secondarily, in preventing or mitigating obesity or hyperlipidemia, benefits reported to occur in adults with exogenous obesity and GHD after GH replacement [1, 5, 7, 8]. The gene discussed is GH1; the disease is Obesity.